Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Wessels

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Infection and Immunity|May 1, 1994
Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccineM B Marques, D L Kasper, A Shroff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1985
Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharidesR E Schifferle, H J Jennings, M R Wessels, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2000
Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old womanF S Lee, F K Chu, M Tackley, et al.
Infection and Immunity|October 1, 1992
Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccineL C Paoletti, M R Wessels, F Michon, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 1995
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunityM R Wessels, P Butko, M Ma, et al.
Infection and Immunity|May 9, 1998
Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacyM R Wessels, L C Paoletti, H K Guttormsen, et al.
Infection and Immunity|January 1, 1997
Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A StreptococcusA E Moses, M R Wessels, K Zalcman, et al.
Infection and Immunity|April 1, 1989
Isolation and characterization of type IV group B Streptococcus capsular polysaccharideM R Wessels, W J Benedí, H J Jennings, et al.
The Journal of Biological Chemistry|October 25, 1990
An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B StreptococcusL C Paoletti, D L Kasper, F Michon, et al.
Infection and Immunity|August 14, 1999
Measurement of human antibodies to type III group B StreptococcusD L Kasper, M R Wessels, H K Guttormsen, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Infection and Immunity|May 1, 1994
Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccineM B Marques, D L Kasper, A Shroff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1985
Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharidesR E Schifferle, H J Jennings, M R Wessels, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2000
Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old womanF S Lee, F K Chu, M Tackley, et al.
Infection and Immunity|October 1, 1992
Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccineL C Paoletti, M R Wessels, F Michon, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 1995
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunityM R Wessels, P Butko, M Ma, et al.
Infection and Immunity|May 9, 1998
Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacyM R Wessels, L C Paoletti, H K Guttormsen, et al.
Infection and Immunity|January 1, 1997
Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A StreptococcusA E Moses, M R Wessels, K Zalcman, et al.
Infection and Immunity|April 1, 1989
Isolation and characterization of type IV group B Streptococcus capsular polysaccharideM R Wessels, W J Benedí, H J Jennings, et al.
The Journal of Biological Chemistry|October 25, 1990
An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B StreptococcusL C Paoletti, D L Kasper, F Michon, et al.
Infection and Immunity|August 14, 1999
Measurement of human antibodies to type III group B StreptococcusD L Kasper, M R Wessels, H K Guttormsen, et al.
Pageof 7